Back
Compass Pathways PLC Vs. Biodexa Pharmaceuticals Plc Industry Stock Comparison
Sell
35
CMPS
Compass Pathways PLC
Last Price:
8.54
Seasonality Move:
27.73%
Sell
46
BDRX
Biodexa Pharmaceuticals Plc
Last Price:
1.19
Seasonality Move:
-17.05%
Sell
35
Compass Pathways PLC (CMPS)
is a Sell
Is Compass Pathways PLC a Buy, Sell or Hold?
- The current Compass Pathways PLC [CMPS] share price is $8.53. The Score for CMPS is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- CMPS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Biodexa Pharmaceuticals Plc (BDRX)
is a Sell
Is Biodexa Pharmaceuticals Plc a Buy, Sell or Hold?
- The current Biodexa Pharmaceuticals Plc [BDRX] share price is $1.18. The Score for BDRX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- BDRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CMPS Stock Price Chart
What is Compass Pathways PLC's stock price today?
-
The Compass Pathways PLC share price today is $8.53
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CMPS is experiencing selling pressure, which indicates risk of future bearish movement.
BDRX Stock Price Chart
What is Biodexa Pharmaceuticals Plc's stock price today?
-
The Biodexa Pharmaceuticals Plc share price today is $1.18
The current trend is relatively stagnant and BDRX is experiencing selling pressure, which indicates risk of future bearish movement.
CMPS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.32 | Sell |
| Relative Strength Index (14 RSI): | 46.66 | Sell |
| Chaikin Money Flow: | -449768 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.15 - 9.39) | Sell |
| Bollinger Bands (100): | (8.29 - 10.65) | Sell |
BDRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 53.16 | Buy |
| Chaikin Money Flow: | -247628 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.81 - 1.27) | Buy |
| Bollinger Bands (100): | (0.98 - 2.24) | Sell |
CMPS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.24 | Buy |
| 20-day SMA: | 8.56 | Sell |
| 50-day SMA: | 9.54 | Sell |
| 200-day SMA: | 8.43 | Buy |
| 8-day EMA: | 8.37 | Buy |
| 20-day EMA: | 8.59 | Sell |
| 50-day EMA: | 9.08 | Sell |
| 200-day EMA: | 8.97 | Sell |
BDRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.16 | Buy |
| 20-day SMA: | 0.99 | Buy |
| 50-day SMA: | 1.13 | Buy |
| 200-day SMA: | 3.12 | Sell |
| 8-day EMA: | 1.17 | Buy |
| 20-day EMA: | 1.09 | Buy |
| 50-day EMA: | 1.22 | Sell |
| 200-day EMA: | 41.31 | Sell |
Compass Pathways PLC Earnings Growth & CMPS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and a decrease next year of $0.12 per share.
Biodexa Pharmaceuticals Plc Earnings Growth & BDRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.03 per share.
Compass Pathways PLC Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biodexa Pharmaceuticals Plc Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||